Litcius/Paper detail

Multi-epitope peptide vaccines targeting dengue virus serotype 2 created via immunoinformatic analysis

Radwa N. Morgan, Nasser S. M. Ismail, Mohammad Y. Alshahrani, Khaled M. Aboshanab

2024Scientific Reports16 citationsDOIOpen Access PDF

Abstract

The Middle East has witnessed a greater spread of infectious Dengue viruses, with serotype 2 (DENV-2) being the most prevalent form. Through this work, multi-epitope peptide vaccines against DENV-2 that target E and nonstructural (NS1) proteins were generated through an immunoinformatic approach. MHC class I and II and LBL epitopes among NS1 and envelope E proteins sequences were predicted and their antigenicity, toxicity, and allergenicity were investigated. Studies of the population coverage denoted the high prevalence of NS1 and envelope-E epitopes among different countries where DENV-2 endemic. Further, both the CTL and HTL epitopes retrieved from NS1 epitopes exhibited high conservancies' percentages with other DENV serotypes (1, 3, and 4). Three vaccine constructs were created and the expected immune responses for the constructs were estimated using C-IMMSIM and HADDOCK (against TLR 2,3,4,5, and 7). Molecular dynamics simulation for vaccine construct 2 with TLR4 denoted high binding affinity and stability of the construct with the receptor which might foretell favorable in vivo interaction and immune responses.

Topics & Concepts

VirologyDengue virusDengue feverDengue vaccineEpitopeSerotypeVirusPeptide vaccineBiologyAntibodyImmunologyvaccines and immunoinformatics approachesViral Infections and Outbreaks ResearchVirology and Viral Diseases
Multi-epitope peptide vaccines targeting dengue virus serotype 2 created via immunoinformatic analysis | Litcius